Your browser doesn't support javascript.
loading
Sensitivity and specificity of the Patient Health Questionnaire (PHQ-9, PHQ-8, PHQ-2) and General Anxiety Disorder scale (GAD-7, GAD-2) for depression and anxiety diagnosis: a cross-sectional study in a Peruvian hospital population.
Villarreal-Zegarra, David; Barrera-Begazo, Juan; Otazú-Alfaro, Sharlyn; Mayo-Puchoc, Nikol; Bazo-Alvarez, Juan Carlos; Huarcaya-Victoria, Jeff.
Afiliación
  • Villarreal-Zegarra D; Escuela de Medicina, Universidad César Vallejo, Trujillo, Peru.
  • Barrera-Begazo J; Instituto Peruano de Orientación Psicológica, Lima, Peru.
  • Otazú-Alfaro S; Instituto Peruano de Orientación Psicológica, Lima, Peru.
  • Mayo-Puchoc N; Instituto Peruano de Orientación Psicológica, Lima, Peru.
  • Bazo-Alvarez JC; Instituto Peruano de Orientación Psicológica, Lima, Peru.
  • Huarcaya-Victoria J; Research Department of Primary Care and Population Health, University College London (UCL), London, UK.
BMJ Open ; 13(9): e076193, 2023 09 15.
Article en En | MEDLINE | ID: mdl-37714674
ABSTRACT

OBJECTIVES:

The Patient Health Questionnaire (PHQ) and Generalised Anxiety Disorder Scale (GAD) are widely used screening tools, but their sensitivity and specificity in low-income and middle-income countries are lower than in high-income countries. We conducted a study to determine the sensitivity and specificity of different versions of these scales in a Peruvian hospital population.

DESIGN:

Our study has a cross-sectional design.

SETTING:

Our participants are hospitalised patients in a Peruvian hospital. The gold standard was a clinical psychiatric interview following ICD-10 criteria for depression (F32.0, F32.1, F32.2 and F32.3) and anxiety (F41.0 and F41.1).

PARTICIPANTS:

The sample included 1347 participants. A total of 334 participants (24.8%) were diagnosed with depression, and 28 participants (2.1%) were diagnosed with anxiety.

RESULTS:

The PHQ-9's≥7 cut-off point showed the highest simultaneous sensitivity and specificity when contrasted against a psychiatric diagnosis of depression. For a similar contrast against the gold standard, the other optimal cut-off points were ≥7 for the PHQ-8 and ≥2 for the PHQ-2. In particular, the cut-off point ≥8 had good performance for GAD-7 with sensitivity and specificity, and cut-off point ≥10 had lower levels of sensitivity, but higher levels of specificity, compared with the cut-off point of ≥8. Also, we present the sensitivity and specificity values of each cut-off point in PHQ-9, PHQ-8, PHQ-2, GAD-7 and GAD-2. We confirmed the adequacy of a one-dimensional model for the PHQ-9, PHQ-8 and GAD-7, while all PHQ and GAD scales showed good reliability.

CONCLUSIONS:

The PHQ and GAD have adequate measurement properties in their different versions. We present specific cut-offs for each version.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Depresión / Cuestionario de Salud del Paciente Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do sul / Peru Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Perú

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Depresión / Cuestionario de Salud del Paciente Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do sul / Peru Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Perú